Daniel Harari

2.8k citations

33 papers · 2.0k indexed · 1 hit paper · h-index 17

Impact in

Oncology top 5%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
Immunology top 10%
- interferon and immune responses

Papers in ⓘ

Oncology 13
- Cytokine Signaling Pathways and Interactions 11
- HER2/EGFR in Cancer Research 3
Immunology 10
- interferon and immune responses 9

Co-authors: Y Yarden (1 shared paper)Gideon Schreiber (13 shared papers)Yosef Yarden (6 shared papers)Jan E. Romano (1 shared paper)Maya Shelly (1 shared paper)Eldad Tzahar (1 shared paper)Doron Levin (2 shared papers)Ami Citri (3 shared papers)
Journals: Journal of Biological Chemistry (3 papers)Molecular and Cellular Biology (3 papers)Cytokine (2 papers)Oncogene (2 papers)PLoS ONE (2 papers)
Partner nations: Israel Germany Switzerland

In The Last Decade

Daniel Harari

30 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution 2021 · 230 citations

Peers

Countries citing papers authored by Daniel Harari

Since Specialization

Citations

This map shows the geographic impact of Daniel Harari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Harari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Harari more than expected).

Fields of papers citing papers by Daniel Harari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Harari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Harari. The network helps show where Daniel Harari may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Harari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Harari Line = papers co-authored together Daniel Harari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Molecular mechanisms underlying ErbB2/HER2 action in breast cancer Oncogene ·Daniel Harari, Y Yarden	2000	463
2	Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase Oncogene ·Daniel Harari, Eldad Tzahar, Jan E. Romano, Maya Shelly, JH Pierce, G C Andrews, Yosef Yarden	1999	245
3	SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution Nature Microbiology ·Jiří Zahradník, Shir Marciano, Maya Shemesh, Eyal Zoler, Daniel Harari, Jeanne Chiaravalli, Bjoern Meyer, Yinon Rudich, Chunlin Li, Ira Marton, Orly Dym, Nadav Elad, Mark G. Lewis, Hanné Andersen, Matthew Gagné, Robert A. Seder, Daniel C. Douek, Gideon Schreiber Hit paper breakdown →	2021	230
4	Hsp90 Recognizes a Common Surface on Client Kinases Journal of Biological Chemistry ·Ami Citri, Daniel Harari, Galit Shohat-Ophir, Parameswaran Ramakrishnan, Judith Gan, Sara Lavi, Miriam Eisenstein, Adi Kimchi, David Wallach, Shmuel Pietrokovski, Yosef Yarden	2006	194
5	Ligand‐Independent Degradation of Epidermal Growth Factor Receptor Involves Receptor Ubiquitylation and Hgs, an Adaptor Whose Ubiquitin‐Interacting Motif Targets Ubiquitylation by Nedd4 Traffic ·Menachem Katz, Keren Shtiegman, Pazit Tal‐Or, Liat Yakir, Yaron Mosesson, Daniel Harari, Yossy Machluf, Hironobu Asao, Thomas M. Jovin, Kazuo Sugamura, Yosef Yarden	2002	128
6	SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon PLoS Pathogens ·Maya Shemesh, Turgut E. Aktepe, Joshua M. Deerain, Julie McAuley, Michelle D. Audsley, Cassandra T. David, Damian F. J. Purcell, Victoria Urin, Rune Hartmann, Gregory W. Moseley, Jason M. Mackenzie, Gideon Schreiber, Daniel Harari	2021	84
7	Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment Molecular and Cellular Biology ·Doron Levin, Daniel Harari, Gideon Schreiber	2011	84
8	Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities Molecular and Cellular Biology ·Ignacio Moraga, Daniel Harari, Gideon Schreiber, Gilles Uzé, Sandra Pellegrini	2009	82
9	Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity Journal of Biological Chemistry ·Bose Kochupurakkal, Daniel Harari, Ayelet Di‐Segni, Galia Maik-Rachline, Ljuba Lyass, Gal Gur, Gabriele Kerber, Ami Citri, Sara Lavi, Raya Eilam, Vered Chalifa‐Caspi, Zelig Eshhar, Eli Pikarsky, Ronit Pinkas‐Kramarski, Sarah Bacus, Yosef Yarden	2004	76
10	ErbB Signaling Regulates Lineage Determination of Developing Pancreatic Islet Cells in Embryonic Organ Culture Endocrinology ·M.-A. Huotari, Päivi J. Miettinen, Jaan Palgi, Tarja Koivisto, Jarkko Ustinov, Daniel Harari, Yosef Yarden, Timo Otonkoski	2002	69
11	Type I Interferons Induce Apoptosis by Balancing cFLIP and Caspase-8 Independent of Death Ligands Molecular and Cellular Biology ·Amir Apelbaum, Ganit Yarden, Shira Warszawski, Daniel Harari, Gideon Schreiber	2012	54
12	Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis Journal of Biological Chemistry ·Daniel Harari, Nadine Kuhn, Renne Abramovich, Keren Sasson, Alla L. Zozulya, Paul Smith, Martin Schlapschy, Rina Aharoni, Mario Köster, Raya Eilam, Arne Skerra, Gideon Schreiber	2014	53
13	Hsp90 increases LIM kinase activity by promoting its homo‐dimerization The FASEB Journal ·Rong Li, Juliana Soosairajah, Daniel Harari, Ami Citri, John T. Price, Hooi Ling Ng, Craig J. Morton, Michael W. Parker, Yosef Yarden, Ora Bernard, Rong Li	2006	49
14	Characterization of a vasa‐like gene from the pacific white shrimp Litopenaeus vannamei and its expression during oogenesis Molecular Reproduction and Development ·Eliahu D. Aflalo, Anna Bakhrat, S. Raviv, Daniel Harari, Amir Sagi, Uri Abdu	2006	47
15	Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response PLoS ONE ·Daniel Harari, Renne Abramovich, Alla L. Zozulya, Paul Smith, Sandrine Pouly, Mario Köster, H. Häuser, Gideon Schreiber	2014	31
16	Coronavirus: Economic impact Daniel Harari, Matthew Keep, Philip Brien	2021	21
17	FGF plays a subtle role in oligodendrocyte maintenance in vivo Journal of Neuroscience Research ·Daniel Harari, David Finkelstein, Ora Bernard	1997	20
18	Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19 ACS Biomaterials Science & Engineering ·Chunlin Li, Ira Marton, Daniel Harari, Maya Shemesh, Vyacheslav Kalchenko, Michal Pardo, Gideon Schreiber, Yinon Rudich	2022	10
19	Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells The Journal of Immunology ·Meihui Xia, Tina YuXuan Luo, Yonghong Shi, Guizhi Wang, Hubert Tsui, Daniel Harari, David Spaner	2020	9
20	Fine Tuning of a Type 1 Interferon Antagonist PLoS ONE ·Victoria Urin, Doron Levin, Nanaocha Sharma, Daniel Harari, Gideon Schreiber	2015	7

About Daniel Harari

Daniel Harari is a scholar working on Oncology, Immunology, General Social Sciences, Genetics and Developmental Neuroscience, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (11 papers), interferon and immune responses (9 papers), Chronic Lymphocytic Leukemia Research (3 papers), HER2/EGFR in Cancer Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Systemic Lupus Erythematosus Research (3 papers), Animal Genetics and Reproduction (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Oncology (672 citations), Immunology (395 citations), Infectious Diseases (319 citations), Molecular Biology (1.0k citations) and Radiology, Nuclear Medicine and Imaging (335 citations). Daniel Harari has collaborated with scholars based in Israel, Germany and Switzerland. Frequent co-authors include Y Yarden, Gideon Schreiber, Yosef Yarden, Jan E. Romano, Maya Shelly, Eldad Tzahar, Doron Levin, Ami Citri, Sara Lavi and Maya Shemesh. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Cytokine, Oncogene and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact